Daiichi Sankyo
Isha Patel is an experienced professional in the fields of drug safety and clinical study startup, currently serving as the Associate Director of Clinical Study Startup at Daiichi Sankyo US since March 2025. Prior to this role, Isha held multiple positions at Insmed Incorporated, including Senior Manager and Manager of Drug Safety and Pharmacovigilance Operations from May 2021 to March 2025. Isha's expertise also includes serving as Clinical Safety Lead at Sanofi from December 2016 to May 2021 and as a Clinical Safety Scientist Consultant at Merck from November 2015 to December 2016. Isha is pursuing a Doctor of Public Health degree at Capella University, scheduled for completion in June 2027, and holds an MBA in Health Care Management from Capella University as well as a Bachelor's degree in Pharmacy from Saurashtra University, Rajkot.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.